Landscape of Prophylactic Strategies Against Human Parainfluenza Virus Type 3
Open Access
- 9 October 2025
- journal article
- review article
- Published by Wiley in Reviews in Medical Virology
- Vol. 35 (6) , e70071
Abstract
Human parainfluenza virus‐type 3 (HPIV3) is a respiratory virus responsible for mild illnesses in most of the population and severe illnesses, such as bronchiolitis and pneumonia, in young children, immunocompromised individuals and the elderly. To date, no vaccines nor antiviral drugs have been approved against HPIV3, despite its significant burden in vulnerable people. In this review, we present both past and current prophylactic strategies against HPIV3, such as live‐attenuated virus, vector‐based, subunit and mRNA vaccine candidates or antibody‐based passive protection. For each strategy, we give an overview of the most promising candidates evaluated in preclinical studies and we report immunogenicity and protection data from clinical trials. Finally, we discuss the most important challenges regarding those vaccine strategies and their potential administration to the different vulnerable populations.Keywords
This publication has 92 references indexed in Scilit:
- Cold-passaged human parainfluenza type 3 viruses contain ts and non-ts mutations leading to attenuation in rhesus monkeysVirus Research, 1992
- Evaluation of the immunogenicity and protective efficacy of a candidate parainfluenza virus type 3 subunit vaccine in cotton ratsVaccine, 1991
- Evaluation of bovine, cold-adapted human, and wild-type human parainfluenza type 3 viruses in adult volunteers and in chimpanzeesJournal of Clinical Microbiology, 1991
- Intranasal Immunization of Hamsters with Envelope Glycoproteins of Human Parainfluenza Virus Type 3The Journal of Infectious Diseases, 1988
- Attenuation of Bovine Parainfluenza Virus Type 3 in Nonhuman Primates and Its Ability to Confer Immunity to Human Parainfluenza Virus Type 3 ChallengeThe Journal of Infectious Diseases, 1988
- Conserved epitopes on the hemagglutinin-neuraminidase proteins of human and bovine parainfluenza type 3 viruses: nucleotide sequence analysis of variants selected with monoclonal antibodiesJournal of Virology, 1986
- Glycoproteins of Human Parainfluenza Virus Type 3: Characterization and Evaluation as a Subunit VaccineThe Journal of Infectious Diseases, 1985
- RESPIRATORY SYNCYTIAL VIRUS DISEASE IN INFANTS DESPITE PRIOR ADMINISTRATION OF ANTIGENIC INACTIVATED VACCINE12American Journal of Epidemiology, 1969
- RESPIRATORY VIRUS IMMUNIZATIONAmerican Journal of Epidemiology, 1969
- Immunogenicity of Inactivated Parainfluenza Type 1, Type 2, and Type 3 Vaccines in InfantsJAMA, 1966